Key points are not available for this paper at this time.
Abstract Background The approved screening test for HCV infection among blood donors is the HCV antibody test. The diagnostic performances of the available immunoassays in the market that target different HCV antigens have not yet been thoroughly analyzed. Our study aimed to assess the diagnostic performances of two different chemiluminescence immunoassay (CLIA) assays. Methods We analyzed 1909 samples using two assay systems (COBAS e601 ROCHE® however, Vitros 3600 ORTHO outperformed Cobas e 601 ROCHE in terms of sensitivity and specificity.
Salem et al. (Fri,) studied this question.